The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
about
Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsFollow-up of patients with mycosis fungoides after interferon α2b treatment failure.Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapyTotal skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemiaApoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and MethotrexateAge, race, sex, stage, and incidence of cutaneous lymphomaAllogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institutionTotal skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique.CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Cutaneous T-cell lymphomas: a review of new discoveries and treatments.Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.Literature review of clinical results of total skin electron irradiation (TSEBT) of mycosis fungoides in adults.Clinical results of the total skin electron irradiation of the mycosis fungoides in adults. Conventional fractionation and low dose schemes.Institutional experience with a rotational total skin electron irradiation (RTSEI) technique-A three decade review (1981-2012).Cherenkov imaging method for rapid optimization of clinical treatment geometry in total skin electron beam therapy.Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study.Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.Dosimetric characterization and optimization of a customized Stanford total skin electron irradiation (TSEI) technique.Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome.The dose penumbra of a custom-made shield used in hemibody skin electron irradiation.Dosimetric characterization and optimization of a customized Stanford Total Skin Electron Irradiation (TSEI) technique.Total Skin Electron Beam Therapy with Rotary Dual Technique as Palliative Treatment for Mycosis Fungoides.
P2860
Q30252152-AC36005C-9A36-4539-ACB7-A8F414F928AAQ33746059-7320AF87-9D9E-4D41-8D9A-1E5A34E8EA3AQ35620524-5FFB9573-7964-4B87-98B6-1D47FC0F0A7EQ35825986-1BE378F1-D9E1-4438-BCFA-06CE8F74024BQ36239776-E9FA7A42-D95E-455E-9F71-AB0BE16F017FQ36255777-B78EA146-C1A4-4ABB-A046-A11456A0005FQ36330634-62AD98FD-D74C-41F5-BA31-45300B520E91Q36865042-7A8FCB25-DA69-4A44-9C21-C42F49D48E85Q36908701-5C7C81E2-1B4D-4835-94D0-690675F49C34Q36999986-F7E73181-B6AF-431B-AE63-8E526141E118Q37944565-B4948AC8-7C2A-49A8-92EB-864DEA673F8EQ37981969-AE2B9E15-6DBF-451B-B481-E76B6964316AQ38212880-EED4406E-1949-4D7E-80E3-2CF5681F54B2Q38220826-0179E528-7E12-4CEB-A8FF-B174BEFF3E80Q38220827-C87CE2AE-ED00-47E0-9EC2-24FD7B91FB70Q38220829-EE790506-3B5D-4EB5-BF9C-D5B1818D399DQ38273494-5A7DE7A6-E2E2-4680-9833-36DECD402F02Q39701541-CC4D6D2B-F98C-42D1-A23A-3966539C818EQ43632085-FCAFB4A2-7FCD-4346-88EA-DD52F398AE6EQ44973040-CFE35768-1940-48B1-AACF-E240A60006D6Q47302497-57257AD7-135A-453D-8FE7-8C782168459CQ48296904-47386775-C814-43AB-B024-503FA2313B22Q51084086-27647144-A33A-421E-8D48-6855B58656F9Q54975756-53FBA62F-30FB-47F3-9BD6-DF3FC9419113Q55465825-1293773E-7B6B-4405-AC06-4B80917C8C7A
P2860
The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Stanford University experi ...... tumor (T3) mycosis fungoides.
@en
The Stanford University experi ...... tumor (T3) mycosis fungoides.
@nl
type
label
The Stanford University experi ...... tumor (T3) mycosis fungoides.
@en
The Stanford University experi ...... tumor (T3) mycosis fungoides.
@nl
prefLabel
The Stanford University experi ...... tumor (T3) mycosis fungoides.
@en
The Stanford University experi ...... tumor (T3) mycosis fungoides.
@nl
P2093
P1433
P1476
The Stanford University experi ...... tumor (T3) mycosis fungoides.
@en
P2093
Daniel Navi
Nadeem Riaz
Naomi C Sullivan
Richard T Hoppe
Yakir S Levin
Youn H Kim
P304
P356
10.1001/ARCHDERMATOL.2011.98
P577
2011-05-01T00:00:00Z